Ligand Pharmaceuticals, Inc. (LGND)
201.90
-4.50
(-2.18%)
USD |
NASDAQ |
Mar 06, 16:00
201.58
-0.32
(-0.16%)
After-Hours: 20:00
Ligand Pharmaceuticals SG&A Expense (TTM) : 92.45M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ADMA Biologics, Inc. | 96.42M |
| Johnson & Johnson | 23.68B |
| Merck & Co., Inc. | 10.73B |
| Globus Medical, Inc. | 1.178B |
| Alnylam Pharmaceuticals, Inc. | 1.211B |